Korean Drug Co.

Korean Drug Co. (고려제약, KDC) is a South Korean pharmaceutical company founded in 1982. According to its official website, it produces and sells both over-the-counter medicines — such as the Korean cold remedy 'Haben' — and prescription medicines for central nervous system (CNS) conditions including dementia, stroke and Parkinson's disease, led by its original brain-function improver 'Neuromed'. The company states it provides a Total Health Solution spanning pharmaceuticals, health functional foods, cosmetics and medical devices, and pursues R&D and open innovation with domestic and overseas research institutions. Its headquarters are in Gangnam-gu, Seoul, and its co-CEOs are Park Hae-ryong and Park Sang-hoon.

Korean Drug Co. was founded in 1982, according to the greeting on its official website. The company states that it produces and sells over-the-counter medicines such as the Korean cold remedy 'Haben' as well as prescription medicines for various diseases including central nervous system (CNS) conditions such as dementia, stroke and Parkinson's disease, led by its original brain-function improver 'Neuromed'. It describes providing a Total Health Solution covering the entire process from diagnosis and treatment to prevention and management, and pursuing active R&D investment and open innovation with excellent domestic and overseas research institutions.

Total Health Solution provider for healthy and active aging, spanning pharmaceuticals, health functional foods, cosmetics and medical devices.

• Haben (하벤)

  A representative Korean cold medicine (over-the-counter).

• Neuromed (뉴로메드)

  An original brain-function improving agent.

• Neurogoline Tab. 30mg (뉴로고린정30밀리그램)

  A dementia treatment that improves cerebral blood flow and neurotransmission and promotes brain metabolic activity; local cerebral blood flow (rCBF) improvement demonstrated in clinical trials, used in more than 50 countries for over 30 years.

• Ginkgo-mexin Tab. 240mg (진코멕신정240mg)

  A memory and concentration improving agent for mental function decline accompanied by symptoms such as reduced concentration, memory decline and dizziness (arteriosclerosis symptoms).

• Neurocept Duo Tab. (뉴로셉트듀오정)

  For moderate to severe Alzheimer's disease; a combination therapy of Donepezil and Memantine for convenient dosing.

• ResQlyte Boost (레스큐라이트부스트액)

  A formulated food for hydration and electrolyte supplementation meeting MFDS standards, with sugars, electrolytes and osmolality adjusted to help recovery from mild dehydration and electrolyte imbalance.

1. 1고려제약nicepharma.com
2. 2고려제약nicepharma.com
3. 3고려제약nicepharma.com
4. 4고려제약nicepharma.com
5. 5Korean Drug Co.wikidata.org